HIV News and Research

RSS

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

At the opening ceremony of the Lausanne, Switzerland, AIDS VACCINE '04 conference, leaders in the field of AIDS vaccine research called for increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines as a public health imperative in fighting HIV/AIDS.

30 Aug 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

Researchers look to make more effective drug treatments for tuberculosis

Tuberculosis isn’t yet making a major comeback in the U.S. but one- third of the world’s population is infected with the disease, and it poses a major danger to health worldwide.

26 Aug 2004

Clinicians have been able to reduce mortality rates in HIV positive children from 15 to 3 percent

"This is perhaps the first time that it has been demonstrated that HIV positive children can be successfully treated with antiretroviral therapy in resource-limited settings and the outcomes are comparable to those we have seen in U.S. pediatric antiretroviral clinical trials,"

23 Aug 2004

Surprise finding could lead to hepatitis C vaccine

New research from the University of New South Wales shows some people may repeatedly be able to clear hepatitis C virus from their bodies, without any biological traces of the potentially serious infection.

23 Aug 2004

New information about how HIV evades eradication from the body

Researchers at the National Cancer Institute, have discovered new information about how human immunodeficiency virus (HIV), the virus that causes acquired immune deficiency (AIDS), possibly evades eradication from the body.

23 Aug 2004

Peginterferon and Ribavirin combination promising for those with HIV and HCV

Since the introduction of highly active combination drug therapy for HIV, liver failure attributable to infection with the hepatitis C virus (HCV) has become a leading cause of death among those infected with the virus that causes AIDS.

22 Aug 2004

First whole-genome survey of where three commonly used retroviruses into human DNA

Retroviruses are one of the most common vehicles for delivering therapeutic payloads via gene therapy in animal models of disease and human patients.

22 Aug 2004

Development of plant-derived topical medications to prevent HIV/AIDS and other STD's

Researchers at the Biodesign Institute at ASU have been tapped to lead development of plant-derived topical medications that would prevent HIV/AIDS and other sexually-transmitted diseases.

21 Aug 2004

Nucleic acid-amplification testing has improved the safety of the nation's blood supply

State-of-the-art testing systems to screen donated blood have improved the safety of the nation's blood supply by preventing the transmission of potentially deadly viruses, according to a new study funded by the National Heart, Lung, and Blood Institute.

18 Aug 2004

The world's population in 2050 will be 9.276 billion, currently 6.396 in 2004

The Population Reference Bureau has released the 2004 World Population Data Sheet. The new data is now the most up-to-date world demographic information and makes estimates for all countries and regions of the world. It also highlights key world demographic shifts between now and 2050.

18 Aug 2004

2004 AIDS Vaccine Conference has announced it's forthcoming programme

The Conference will examine the entire spectrum of issues in AIDS vaccine development and deployment, including the global effort in preventative and therapeutic vaccines, immunology, pediatric and adolescent vaccines, clinical trials in emerging countries and the need for strong political and financial commitment.

17 Aug 2004

South Africa will continue providing Nevirapine as monotherapy to mothers and babies

The South African Government's policy to reduce the risk of mother to child transmission of HIV, remains unchanged.

17 Aug 2004

Revolutionary new test for identifying people infected with tuberculosis

The test – named T SPOT-TB – is designed to replace the century old skin test for TB, which is currently given to 600,000 UK schoolchildren every year. The test comes from discoveries made over the last 10 years at the University of Oxford by Dr Aljit Lalvani and collaborators at the Nuffield Department of Medicine.

16 Aug 2004

Discovery of new ways to manipulate AIDS virus

16 Aug 2004

Drug interactions between prescription medication and herbal supplements can be extremely dangerous

Herbal supplements may be natural, but that doesn’t necessarily mean that they are safe.

11 Aug 2004

Survey reveals surprising insights into parental attitudes toward teenage sexual behavior

As an estimated four million American children make the transition from junior high/middle school to high school this fall, a new national survey conducted by the Society for Adolescent Medicine reveals parents' primary concerns as they ready their teenagers for the new school year.

11 Aug 2004

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

The market for disposable surgical drapes and gowns in Europe has seen steady growth in the recent past owing to the high standards of infection control enforced by the new European Union Medical Device Directive (MDD) and EU regulations.

11 Aug 2004

$5 million to assist Pacific island nations develop and implement country-specific HIV/AIDS prevention

Australia will provide $5 million for a Pacific HIV/AIDS Grant Scheme to assist Pacific island nations develop and implement country-specific HIV/AIDS prevention and information campaigns.

11 Aug 2004

People living with HIV in rural communities may face different barriers to taking proper care of themselves

People who live with HIV in rural areas are less likely to keep up with their treatment schedules if they are problem drinkers, say Tulane University researchers. Overall, about one in three HIV positive people surveyed by the researchers reported skipping at least one dose of their medications in the past week.

7 Aug 2004

HIV News and Research

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

FDA reinforces use of Sustiva in first-line HIV combination therapy

Researchers look to make more effective drug treatments for tuberculosis

Clinicians have been able to reduce mortality rates in HIV positive children from 15 to 3 percent

Surprise finding could lead to hepatitis C vaccine

New information about how HIV evades eradication from the body

Peginterferon and Ribavirin combination promising for those with HIV and HCV

First whole-genome survey of where three commonly used retroviruses into human DNA

Development of plant-derived topical medications to prevent HIV/AIDS and other STD's

Nucleic acid-amplification testing has improved the safety of the nation's blood supply

The world's population in 2050 will be 9.276 billion, currently 6.396 in 2004

2004 AIDS Vaccine Conference has announced it's forthcoming programme

South Africa will continue providing Nevirapine as monotherapy to mothers and babies

Revolutionary new test for identifying people infected with tuberculosis

Discovery of new ways to manipulate AIDS virus

Drug interactions between prescription medication and herbal supplements can be extremely dangerous

Survey reveals surprising insights into parental attitudes toward teenage sexual behavior

Dynamics between disposable and reusable segments affect expansion of disposable drapes and gowns markets

$5 million to assist Pacific island nations develop and implement country-specific HIV/AIDS prevention

People living with HIV in rural communities may face different barriers to taking proper care of themselves

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News